Literature DB >> 30787617

Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer.

Rong Yang1, Yihe Wu2,3, Linpeng Yao1, Jinming Xu2, Siying Zhang1, Chengli Du2, Feng Chen1.   

Abstract

PURPOSE: This study investigated the perioperative risk factors of postoperative pulmonary complications (PPCs) after minimally invasive anatomic resection for lung cancer. PATIENTS AND METHODS: We retrospectively reviewed the data from medical records of 729 lung cancer patients undergoing minimally invasive anatomic lung resections between January 2017 and December 2017. Univariate and binary logistic regression analyses were performed to select the independent risk factors for PPCs during the patient's postoperative hospitalization after surgery.
RESULTS: The incidence of PPCs was 24.8% (n=181/729). No patient died during the period of hospitalization. Logistic regression analysis revealed that body mass index (BMI) ≥24.0 kg/m2 (vs <24.0 kg/m2: OR 1.514, 95% CI 1.057-2.167, P=0.024), single segmentectomy (vs single lobectomy: OR 2.115, 95% CI 1.150-3.891, P=0.016), bilobectomy or combined lobectomy and segmentectomy (vs single lobectomy: OR 2.731, 95% CI 1.013-7.361, P=0.047), and right lung lobe surgery (vs left lung lobe surgery: OR 1.519, 95% CI 1.046-2.205, P=0.028) were independent risk factors for PPCs in lung cancer patients who received minimally invasive anatomic lung resections.
CONCLUSION: Individual factors such as BMI ≥24.0 kg/m2, single segmentectomy, bilobectomy or combined lobectomy and segmentectomy, and right lung lobe surgery were independent risk factors of PPCs, which should be helpful for risk stratification, patient counseling, and perioperative care for lung cancer patients.

Entities:  

Keywords:  lung cancer; minimally invasive lung resection; postoperative pneumonia; postoperative pulmonary complications; risk factors

Year:  2019        PMID: 30787617      PMCID: PMC6366351          DOI: 10.2147/TCRM.S195010

Source DB:  PubMed          Journal:  Ther Clin Risk Manag        ISSN: 1176-6336            Impact factor:   2.423


Introduction

Lung cancer is the leading cause of cancer death worldwide for both genders, and anatomic lung resection is widely considered the optimal therapy for early-stage lung cancer.1 Video-assisted thoracoscopic surgery or robotic-assisted thoracoscopic surgery is being increasingly performed for early-stage lung cancer instead of open thoracotomy because of its minimally invasive nature.2 Despite the improvement in surgical techniques, postoperative pulmonary complications (PPCs) still occur in 12%–40% of patients after surgical lung resection, and increase hospital mortality, postoperative length of stay (PLOS), and total hospital care costs.1 Several previous studies have suggested that the patient’s age, gender, and body mass index (BMI), as well as smoking and COPD, are risk factors of PPCs after lung resection.3–5 However, data regarding the risk factors of PPCs after lung resection are still limited and often from small sample sizes.3–6 Moreover, there are too many perioperative associated factors for PPCs after lung resection, many of which are still are not being studied and understood. Therefore, further research is needed to address this knowledge gap. In this study, we retrospectively reviewed patients with lung cancer undergoing minimally invasive anatomic resection and compared the perioperative factors between patients with PPCs and patients with no PPCs. The study aimed to identify perioperative risk factors for the development of PPCs after minimally invasive anatomic resection for lung cancer. Knowledge about these factors might help to identify patients at elevated risk for the development of PPCs and, therefore, contribute to a decrease in such complications.

Patients and methods

The Medical Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China, approved the study. Because the data were recorded retrospectively and without any specific intervention, the Medical Ethics Committee agreed to waive the need for informed consent. Data were deidentified to protect the privacy and maintain confidentiality of patient information. It was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments covering patient data confidentiality.

Study population

We retrospectively collected the records of consecutive lung cancer patients who had undergone anatomic lung resections between January 2017 and December 2017, at the First Affiliated Hospital, College of Medicine, Zhejiang University. The inclusion criteria were 1) patients aged over 18 years, 2) patients who had undergone minimally invasive anatomic lung resections under general anesthesia with double-lumen intubation, and 3) pathological confirmation of lung cancer. Minimally invasive anatomic lung resection was defined as lobectomy or segmentectomy under video-assisted thoracoscopic surgery or robotic-assisted thoracoscopic surgery. Exclusion criteria were patients who had undergone 1) open surgery and 2) conversion to thoracotomy. A total of 922 patient records were evaluated, but 193 were excluded because of open surgery (n=162), conversion to thoracotomy (n=27), or incomplete data (n=4). Finally, 729 valid cases were included (Figure 1).
Figure 1

Flow diagram of the cohort selection.

Detailed patient data of the whole cohort are provided in Tables 1 and 2. A low-tidal-volume ventilation strategy was implemented during single lung ventilation. All patients received prophylactic first/second-generation cephalosporins until removal of chest tubes. However, if the patient was diagnosed with a postoperative infection, the antibiotic was adjusted to sulbactam, ampicillin, and ciprofloxacin. If there was no risk of aspiration, the patients were started on oral feedings in the sixth to eighth postoperative hour.
Table 1

Preoperative factors of patients with or without postoperative pulmonary complications by univariate analysis (n=729)

CharacteristicsEntire cohort (n=729)Univariate analysis
Postoperative pulmonary complications group (n=181)No postoperative pulmonary complications group (n=548)P-value
Age (years)57.9±8.557.8±8.858.0±8.40.842
Gender (female/male)461/268116/65345/2030.784
Weight (kg)60.5±10.261.1±10.660.3±10.00.317
Body mass index (kg/m2)22.9±3.023.1±3.222.8±2.90.305
Body mass index grading0.009
 <24.0 kg/m2485 (66.5%)106 (58.6%)379 (69.2%)
 ≥24.0 kg/m2244 (33.5%)75 (41.4%)169 (30.8%)
Smoking (pack-years)9.1±19.99.6±18.68.9±20.30.702
Diabetes mellitus51 (7.0%)11 (6.1%)40 (7.3%)0.576
Hypertension193 (26.5%)44 (24.3%)149 (27.2%)0.446
Coronary heart disease10 (1.4%)0 (0.0%)10 (1.8%)0.131
History of lung surgery or chest trauma17 (2.3%)2 (1.1%)15 (2.7%)0.207
Preoperative renal insufficiency5 (0.7%)2 (1.1%)3 (0.5%)0.602
FEV1 (percentage of predicted value)92.0%±17.0%92.0%±16.3%91.9%±17.2%0.977
FVC (percentage of predicted value)92.3%±15.5%91.4%±15.3%92.6%±15.5%0.368
Peak expiratory flow (percentage of predicted value)68.8%±24.3%70.0%±25.9%68.4%±23.8%0.423
American Society of Anesthesiologists (ASA) physical status classification0.750
 ASA I366 (50.2%)95 (52.5%)271 (49.5%)
 ASA II348 (47.7%)82 (45.3%)266 (48.5%)
 ASA III15 (2.1%)4 (2.2%)11 (2.0%)
Pathology0.072
 Adenocarcinoma, n665 (91.2%)159 (87.8%)506 (92.3%)
 Squamous cell carcinoma, n43 (5.9%)14 (7.7%)29 (5.3%)
 Adenosquamous carcinoma, n10 (1.4%)2 (1.1%)8 (1.5%)
 Small-cell lung cancer, n11 (1.5%)6 (3.3%)5 (0.9%)

Note: Values are presented as mean ± SD, n, or n (%).

Table 2

Intraoperative and postoperative factors of patients with or without postoperative pulmonary complications by univariate analysis (n=729)

CharacteristicsEntire cohort (n=729)Univariate analysis
Postoperative pulmonary complications group (n=181)No postoperative pulmonary complications group (n=548)P-value
Type of minimally invasive surgery0.187
Video-assisted thoracoscopic surgery673 (92.3%)163 (90.1%)510 (93.1%)
Robotic-assisted thoracoscopic surgery56 (7.7%)18 (9.9%)38 (6.9%)
Type of anatomical lung resection0.007
 Single lobectomy654 (89.7%)153 (84.5%)501 (91.4%)
 Single segmentectomy58 (8.0%)19 (10.5%)39 (7.1%)
 Bilobectomy or combined lobectomy and segmentectomy17 (2.3%)9 (5.0%)8 (1.5%)
Surgical lobe0.020
 Left lung lobe283 (38.8%)57 (31.5%)226 (41.2%)
 Right lung lobe446 (61.2%)124 (68.5%)322 (58.8%)
Intraoperative bleeding, mL47.2±32.551.9±36.045.6±31.20.024
Intraoperative bleeding grading0.027
 <50 mL290 (39.8%)57 (31.5%)233 (42.5%)
 50 mL to <100 mL354 (48.6%)98 (54.1%)256 (46.7%)
 ≥100 mL85 (11.7%)26 (14.4%)59 (10.8%)
Intraoperative urine output, mL391.2±318.4376.2±325.3396.1±316.30.466
Amount of intraoperative fluids, mL
 Total1,527.0±412.81,479.0±395.01,542.9±417.70.071
 Crystalloid1,250.6±378.31,222.1±357.41,260.0±384.80.242
 Colloid276.4±258.3256.9±250.6282.8±260.60.242
 Blood000
Amount of net intraoperative total fluid, mL1,088.7±452.31,050.9±461.01,101.1±449.10.195
Length of operation (minutes)131.2±35.1133.4±35.5130.5±35.00.330
Length of operation grading0.169
 <90 minutes86 (11.8%)15 (8.3%)71 (13.0%)
 90 minutes to <150 minutes435 (59.7%)108 (59.7%)327 (59.7%)
 ≥150 minutes208 (28.5%)58 (32.0%)150 (27.4%)
Length of anesthesia (minutes)158.4±37.4162.4±38.3157.1±37.00.098
Length of anesthesia grading0.040
 <120 minutes113 (15.5%)23 (12.7%)90 (16.4%)
 120 minutes to <180 minutes418 (57.3%)96 (53.0%)322 (58.8%)
 ≥180 minutes198 (27.2%)62 (34.3%)136 (24.8%)
Total intravenous crystalloid infusion in the postoperative 48 hours, mL2,459.8±569.12,491.9±616.22,449.2±552.80.171
Total intravenous colloid infusion in the postoperative 48 hours, mL000

Note: Values are presented as mean ± SD, n, or n (%).

Variables and outcomes of interest

The variables comprised preoperative, intraoperative, and postoperative factors, extracted from medical records, as described in Tables 1 and 2. According to the Health Industry Standard of China: Adult Weight Determination (WS/T428-2013), nutritional status is divided into four levels: underweight (BMI <18.5 kg/m2), normal weight (18.5≤ BMI <24.0 kg/m2), pre-obesity (24.0≤ BMI <28.0 kg/m2), and obesity (BMI ≥28.0 kg/m2). Therefore, we used BMI of 24 kg/m2 as the boundary for BMI grading. Preoperative renal insufficiency was defined as creatinine >50% the upper limit of the reference range, which is 1.3 and 1.1 mg/dL for men and women, respectively.7 The amount of total intra-operative fluids was defined as the volumes of crystalloid, colloid, and blood products administered between initiation of anesthesia care and arrival in the postanesthesia care unit.7 The colloid was hydroxyethyl starch. The net intraoperative total fluid was equal to the total intraoperative fluids minus intraoperative bleeding and urine output. Postoperative pathology of lung cancer included adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, and small-cell lung cancer. The PPCs included acute respiratory distress syndrome, reintubation, pneumonia, the need for bedside bronchoscopy, atelectasis, pulmonary embolism, prolonged air leak, and failure to expand during the period of postoperative hospitalization, as reported elsewhere.8 The three criteria used to diagnose postoperative pneumonia were a new pulmonary infiltrate on chest X-ray, leukocytosis, and fever (ear temperature ≥38.0°C).8,9 Bedside bronchoscopy was used to clear lung secretions in the ward after the operation. Atelectasis was diagnosed by chest X-ray or computed tomography (CT), and pulmonary embolism was diagnosed by pulmonary artery CT angiography. A prolonged air leak was defined as leak >7 days.8 Failure to expand was accepted as the inability of the remaining lung to completely fill the pleural cavity with or without air leak, which was diagnosed by chest X-ray.8 The PLOS was defined as the number of hospitalized days after surgery. Hospital costs were the total hospital care costs. Among the 729 patients, 181 (24.8%) had PPCs and were classified into a PPCs group. The remaining 548 (75.2%) patients without PPCs were classified into the no PPCs group.

Statistical analysis

Potential risk factors were detected using single-factor analysis. Continuous data were analyzed using one-way variance analysis. If the variance was not homogeneous, a nonparametric test (Kruskal–Wallis H-test for multiple independent samples) was used. Categorical variables were compared by the R×C chi-squared test or Fisher’s exact test, as appropriate. The potential risk factors with P<0.05 were further assigned, imported into the binary logistic regression equation, and analyzed. Table S1 shows the assignment of variables in binary logistic regression analysis. P<0.05 was considered statistically significant. The OR and 95% CI were calculated. All analyses were performed using SPSS 25.0 (SPSS, Inc., Chicago, IL, USA).7,10

Results

Patient selection and clinical outcomes

A total of 729 patients met our criteria for analysis (Figure 1). The incidence of PPCs was 24.8% (n=181). The four most common PPCs were pneumonia (n=148, 20.3%), failure to expand (n=22, 3.0%), atelectasis (n=16, 2.2%), and prolonged air leak (n=16, 3.0%). No patient died during the period of hospitalization. The PLOS and total hospital care costs in the PPCs group were significantly higher than those in the no PPCs group (Table 3).
Table 3

Clinical outcomes of patients with or without postoperative pulmonary complications

VariablesEntire cohort (n=729)Univariate analysis
Postoperative pulmonary complications group (n=181)No postoperative pulmonary complications group (n=548)P-value
Total number of pulmonary complications, n2142140
Acute respiratory distress syndrome, n3 (0.4%)3 (1.7%)0
Reintubation, n0 (0.0%)0 (0.0%)0
Atelectasis, n16 (2.2%)16 (8.8%)0
Pulmonary embolism, n2 (0.3%)2 (1.1%)0
Need for bedside bronchoscopy, n7 (1.0%)7 (3.9%)0
Pneumonia, n148 (20.3%)148 (81.8%)0
Prolonged air leak, n16 (2.2%)16 (8.8%)0
Failure to expand, n22 (3.0%)22 (12.2%)0
Patients with pulmonary complications, n181 (24.8%)181 (100.0%)0
In-hospital mortality, n000
Postoperative length of stay, days5.8±2.17.0±3.15.4±1.40.000
Total hospital care costs (RMB)61,642.5±13,897.566,794.0±14,847.759,941.0±13,146.20.000

Note: Values are presented as mean ± SD, n, or n (%).

Comparative univariate analysis of the potential risk factors of PPCs

Univariate analysis was performed to determine the potential risk factors for PPCs after minimally invasive anatomic resection for lung cancer. Compared to the no PPCs group, the PPCs group demonstrated significant differences in BMI grading (P=0.009), type of anatomical lung resection (P=0.007), surgical lobe (P=0.020), intraoperative bleeding (P=0.024), intraoperative bleeding grading (P=0.027), and length of anesthesia grading (P=0.040), while there were no discrepancies among the other variables (Tables 1 and 2).

Binary logistic regression analysis of the risk factors of PPCs

We included statistically significant factors in univariate analysis, namely, BMI grading, type of anatomical lung resection, surgical lobe, intraoperative bleeding grading, and length of anesthesia grading, in our binary logistic regression model, to evaluate the perioperative predictors of PPCs. Binary logistics regression analysis demonstrated that BMI grading (≥24.0 kg/m2 vs <24.0 kg/m2: OR 1.514, 95% CI 1.057–2.167, P=0.024), type of anatomical lung resection (single segmentectomy vs single lobectomy: OR 2.115, 95% CI 1.150–3.891, P=0.016; bilobectomy or combined lobectomy and segmentectomy vs single lobectomy: OR 2.731, 95% CI 1.013–7.361, P=0.047), and surgical lobe (right vs left lung lobe: OR 1.519, 95% CI 1.046–2.205, P=0.028) were independent risk factors of PPCs after minimally invasive anatomic resection for lung cancer (Table 4).
Table 4

Logistic model of risk factors for postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer

VariablesOR of postoperative pulmonary complications (95% CI)P-value
Body mass index grading (≥24.0 kg/m2 vs <24.0 kg/m2)1.514 (1.057–2.167)0.024
Type of anatomical lung resection0.009
Single lobectomy1.000
Single segmentectomy2.115 (1.150–3.891)0.016
Bilobectomy or combined lobectomy and segmentectomy2.731 (1.013–7.361)0.047
Surgical lobe (right lung lobe vs left lung lobe)1.519 (1.046–2.205)0.028
Intraoperative bleeding grading0.198
 <50 mL1.000
 50 mL to <100 mL1.430 (0.966–2.117)0.074
 ≥100 mL1.355 (0.750–2.449)0.315
Length of anesthesia grading0.156
 <120 minutes1.000
 120 minutes to <180 minutes1.177 (0.695–1.995)0.544
 ≥180 minutes1.647 (0.918–2.953)0.094

Note: Results of binary logistics regression analysis are presented as adjusted OR, 95% CI, and P-value.

Discussion

This study has shown a PPC frequency of 24.8% in lung cancer patients undergoing minimally invasive anatomic resection, which is still associated with significantly poor short-term outcomes, including increased PLOS and total hospital care costs (Table 3). No patient died during the period of hospitalization. Furthermore, four independent risk factors for PPCs after minimally invasive anatomic resection for lung cancer were identified: BMI ≥24.0 kg/m2, single segmentectomy, bilobectomy or combined lobectomy and segmentectomy, and right lung lobe surgery (Table 4). The incidence of PPCs after lung resection varies. Agostini et al11 reported frequencies of 7.4%, and Lugg et al6 documented a prevalence of 13.0%, whereas Arslantas et al8 noted that PPCs occurred in 54.7% patients after lung resection. This fluctuation is due to the differences in the definition of PPCs. In the current study, PPCs were defined similarly to Arslantas et al,8 which included acute respiratory distress syndrome, reintubation, pneumonia, need for bedside bronchoscopy, atelectasis, pulmonary embolism, prolonged air leak, and failure to expand during the period of postoperative hospitalization. Our incidence of PPCs was 24.8%, which was compatible with the reported frequency.1 In our series, the four most frequent complications were pneumonia (20.3%), failure to expand (3.0%), atelectasis (2.2%), and prolonged air leak (3.0%) (Table 3). No reintubation was identified in our series. BMI is a well-known risk factor for PPCs.1 Being underweight or overweight has been shown to increase the risk of PPCs after lung resection.12 Our data demonstrated that the risk of PPCs in patients with BMI ≥24.0 kg/m2 was higher than in patients with BMI <24.0 kg/m2 (OR 1.514, 95% CI 1.057–2.167, P=0.024) (Table 4). Obese patients often have reduced lung volume, altered ventilation pattern, and comorbid conditions, which are risk factors for intra-and postoperative complications.13,14 Being overweight is an important influencing factor on pre- and postoperative immune function.15 Additionally, an elevated BMI in patients will lead to increased difficulty during surgery and prolonged operative times.16 The prevalence of overweight and obesity is showing an upward trend.17 Thoracic surgeons will encounter more overweight and obese lung cancer patients in the future. Therefore, it was important to find whether BMI ≥24.0 kg/m2 negatively impacts on outcomes after minimally invasive anatomic lung resection. Although a BMI ≥24.0 kg/m2 is not a contradiction for surgery, it should be considered when deciding to perform anatomic lung resection, given its strong association with PPCs. Lobectomy has been the standard procedure for surgical treatment of non-small-cell lung cancer. In recent years, there has been growing evidence suggesting that segmentectomy can yield results equivalent to lobectomy in patients with early non-small-cell lung cancer.18 However, few reports have investigated postoperative complications exclusively in patients with lung cancer undergoing lobectomy or segmentectomy. In the present investigation, compared with single lobectomy, single segmentectomy and bilobectomy or combined lobectomy and segmentectomy were associated with an increased risk of PPCs (Table 4). Why is segmentectomy more prone to PPCs? Patients after segmentectomy had worse mean FEV1 than after lobectomy.19 When performing segmentectomy, surgeons have to divide the intersegmental plane using staplers or electrocautery, which may cause postoperative air leak and development of PPCs.18 Moreover, frequent clamping and pulling of the healthy lung tissue during segmentectomy would lead to postoperative pulmonary edema and development of PPCs.20 Unsurprisingly, bilobectomy or combined lobectomy and segmentectomy were associated with the development of PPCs because they produce greater trauma and more lung surface wound than single lobectomy. Little information about the effects of lung surgery, performed on different lung lobes, on postoperative outcomes has been published to date. Our multivariate analysis revealed that patients undergoing right lung lobe surgery had an increased risk of PPCs (Table 4). The association is possibly related to the difference in lung volume between the left and right lung (ratio of right and left lung volume, 1.22±0.14),21 so the right lung lobe surgery has a greater impact on lung function, resulting in greater trauma and a higher risk of PPCs. In addition, because most of the bilobectomy or combined lobectomy and segmentectomy surgeries involved the right lung (15/17), the surgery of the right lung lobe was associated with an increasing risk of PPCs.

Limitations

There were several limitations to this study. First, it was a single-center retrospective analysis, which may restrict the wide usage of our indications in clinics. A prospective multi-center study would be necessary to validate the risk factors of PPCs identified in our research and to define the best predictors of PPCs more rigorously. Second, numerous perioperative variables can lead to PPCs, but it is unlikely that all of these possible variables will be included in the study. Third, we only followed up our patients during their hospitalization. Hence, longitudinal studies are needed to evaluate the long-term clinical impacts of PPCs.

Conclusion

We identified several perioperative risk factors of PPCs following minimally invasive anatomic resection for lung cancer, including BMI ≥24.0 kg/m2, single segmentectomy, bilobectomy or combined lobectomy and segmentectomy, and right lung lobe surgery. These results should be helpful for risk stratification, patient counseling, and perioperative care of lung cancer patients. Further studies are necessary to validate these findings and create a clinical scoring system to predict PPCs. Assignment of variables in binary logistics regression analysis
Table S1

Assignment of variables in binary logistics regression analysis

VariablesAssignment instruction
Body mass index grading<24.0 kg/m2 =1≥24.0 kg/m2 =2
Type of anatomical lung resectionSingle lobectomy =1Single segmentectomy =2Bilobectomy or combined lobectomy and segmentectomy =3
Surgical lobeLeft lung lobe =1Right lung lobe =2
Intraoperative bleeding grading<50 mL =150 mL to <100 mL =2≥100 mL =3
Length of anesthesia grading<120 minutes =1120 minutes to <180 minutes =2≥180 minutes =3
  21 in total

1.  The results of surgery under general anesthesia in patients with lung cancer.

Authors:  Ryuichi Suemitsu; Sadanori Takeo; Motoharu Hamatake; Akiko Morokuma; Yasuhiko Suemori; Hiroyuki Tanaka
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

2.  Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection.

Authors:  Yasuo Sekine; Hidemi Suzuki; Yoshito Yamada; Eitetsu Koh; Ichiro Yoshino
Journal:  Thorac Cardiovasc Surg       Date:  2012-04-25       Impact factor: 1.827

3.  Association of body mass index and outcomes after major lung resection.

Authors:  Mark K Ferguson; Hae Kyung Im; Sydeaka Watson; Elizabeth Johnson; Christopher H Wigfield; Wickii T Vigneswaran
Journal:  Eur J Cardiothorac Surg       Date:  2014-02-05       Impact factor: 4.191

4.  Thirty-day outcomes after lobectomy or segmentectomy for lung cancer surgery.

Authors:  Takashi Ohtsuka; Ikuo Kamiyama; Keisuke Asakura; Mitsutomo Kohno
Journal:  Asian Cardiovasc Thorac Ann       Date:  2015-06-12

5.  Epidural analgesia is associated with improved health outcomes of surgical patients with chronic obstructive pulmonary disease.

Authors:  Felix van Lier; Patrick J van der Geest; Sanne E Hoeks; Yvette R B M van Gestel; Jaap W Hol; Don D Sin; Robert Jan Stolker; Don Poldermans
Journal:  Anesthesiology       Date:  2011-08       Impact factor: 7.892

6.  Impact of COPD on postoperative outcomes: results from a national database.

Authors:  Himani Gupta; Bala Ramanan; Prateek K Gupta; Xiang Fang; Ann Polich; Ariel Modrykamien; Dan Schuller; Lee E Morrow
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

7.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  Effect of the amount of intraoperative fluid administration on postoperative pulmonary complications following anatomic lung resections.

Authors:  Mustafa Kemal Arslantas; Hasan Volkan Kara; Beliz Bilgili Tuncer; Bedrettin Yildizeli; Mustafa Yuksel; Korkut Bostanci; Nural Bekiroglu; Alper Kararmaz; Ismail Cinel; Hasan F Batirel
Journal:  J Thorac Cardiovasc Surg       Date:  2014-09-18       Impact factor: 5.209

9.  Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage I lung cancer.

Authors:  Mark Shapiro; Todd S Weiser; Juan P Wisnivesky; Cynthia Chin; Michael Arustamyan; Scott J Swanson
Journal:  J Thorac Cardiovasc Surg       Date:  2009-04-11       Impact factor: 5.209

10.  Long-term impact of developing a postoperative pulmonary complication after lung surgery.

Authors:  Sebastian T Lugg; Paula J Agostini; Theofano Tikka; Amy Kerr; Kerry Adams; Ehab Bishay; Maninder S Kalkat; Richard S Steyn; Pala B Rajesh; David R Thickett; Babu Naidu
Journal:  Thorax       Date:  2016-02       Impact factor: 9.139

View more
  6 in total

1.  CT-defined visual emphysema in smokers with normal spirometry: association with prolonged air leak and other respiratory complications after lobectomy for lung cancer.

Authors:  Taeyoung Yun; Hyewon Choi; Hyungjin Kim; Kwon Joong Na; Samina Park; In Kyu Park; Chang Hyun Kang; Jin Mo Goo; Young Tae Kim
Journal:  Eur Radiol       Date:  2022-01-29       Impact factor: 5.315

2.  Analysis of perioperative complications and related risk factors of thoracotomy and complete video-assisted thoracoscopic surgery lobectomy.

Authors:  Hongwei Su; Guorong Yan; Zijian Li; Lin Fu; Lingdi Li
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

3.  Interactions between the enhanced recovery after surgery pathway and risk factors for lung infections after pulmonary malignancy operation.

Authors:  Xianfei Zhang; Runsen Jin; Yuyan Zheng; Dingpei Han; Kai Chen; Jian Li; Hecheng Li
Journal:  Transl Lung Cancer Res       Date:  2020-10

4.  Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator.

Authors:  Nozomu Motono; Masahito Ishikawa; Shun Iwai; Aika Yamagata; Yoshihito Iijima; Hidetaka Uramoto
Journal:  BMC Surg       Date:  2022-05-14       Impact factor: 2.030

5.  Risk Factors of Pulmonary Complications After Minimally Invasive Surgery for Elderly Patients with Vertebral Compression Fractures.

Authors:  Hua-Xing Zhang; Yong Shen; Jia Chen; Long Zhang; Wei Lin
Journal:  Ther Clin Risk Manag       Date:  2020-01-13       Impact factor: 2.423

6.  Sugammadex for reversing neuromuscular blockages after lung surgery: A systematic review and meta-analysis.

Authors:  Jia-Li Yang; Kuen-Bao Chen; Mei-Ling Shen; Wei-Ti Hsu; Yu-Wen Lai; Chieh-Min Hsu
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.